News
Insights advance clinical development, inform trial design and recruitment, substantiate value narratives, and inform patient-specific intervention plans Waltham, MA, September 21, 2021 —CorEvitas, LLC, the gold-standard leader in longitudinal real-world data in autoimmune and inflammatory diseases...Learn More
News
Waltham, MA and London, UK, August 3, 2021 —CorEvitas, LLC welcomes Amrit Ray, MD, MBA, to its Board of Directors. CorEvitas [kohr-eh'-vi-tahs] is the built-for-purpose provider of gold-standard real-world evidence, striving to advance patient care by generating high quality curated data on newly...Learn More
News
Retina specialty data provider combines with leader in real-world evidence Waltham, MA, USA, London, UK, and Naperville, IL, USA, July 22, 2021—CorEvitas, LLC is pleased to share the addition of Vestrum Health to its organization. Vestrum Health, the first-to-market leader in data analytics of...Learn More
News
WALTHAM, MA and BEVERLY HILLS, CA — June 22, 2021 /PRNewswire/ — CorEvitas, LLC and The Guthy-Jackson Charitable Foundation (GJCF) announce first patient enrollment in the SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions in NMOSD) Registry for Neuromyelitis...Learn More